DEPLOYDatabase

Robot model

RNS System

biometriccommercialby NeuroPace

FDA-approved implantable responsive neurostimulation system for focal epilepsy.

Track RNS System
Manufacturer
NeuroPace
Form factor
biometric
Maturity
commercial
Lifecycle
active
Deployments
3

The verified answer

As of Sep 2026, DEPLOY verifies RNS System, a biometric by NeuroPace (commercial): 3 verified deployments on record. 1 source back the record.

Overview

FDA-approved implantable responsive neurostimulation system for focal epilepsy. Continuously monitors and responds to abnormal brain activity.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Form Factor

biometric

Maturity

commercial

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for RNS System. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (3)

Free to use on your site, with a link back to DEPLOY.

RNS System on the deployment map

View the global map

Where RNS System is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for RNS System.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://www.epilepsy.com/stories/fda-approves-responsive-neurostimulation-therapy-neuropace

Common questions

What is RNS System?
FDA-approved implantable responsive neurostimulation system for focal epilepsy. Continuously monitors and responds to abnormal brain activity.
How much does RNS System cost?
RNS System's price is not publicly disclosed. DEPLOY has no verified price on record for RNS System from NeuroPace. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is RNS System actually deployed in the real world?
Yes. RNS System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes RNS System?
RNS System is made by NeuroPace, based in Mountain View, California, USA.
Where is RNS System deployed?
3 verified deployments of RNS System are on the DEPLOY registry, including at United States (comprehensive epilepsy centers), Los Angeles, California, USA, United States (comprehensive epilepsy centers nationwide).
Can you buy RNS System?
RNS System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to RNS System?
On the DEPLOY registry, comparable biometric robots to RNS System include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, Amazfit (Balance / Active / T-Rex / Helio).
How does RNS System compare to Blackrock Neuroport Array?
RNS System and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. RNS System has 3 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is RNS System a top biometric?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, RNS System ranks in roughly the top 30% of biometric models tracked by the registry.
What is RNS System's maturity stage?
RNS System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is RNS System safe?
RNS System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for RNS System.

Recent coverage

RNS System in third-party press

NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data - MarketBeat

Jul 28, 2026

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting - BioSpace

Apr 9, 2025

Kootenai Health First in Idaho to Offer NeuroPace for Epilepsy - Kootenai Health

Feb 5, 2025